Ganglioside complexes: new autoantibody targets in Guillain-Barré syndromes.
Willison
Hugh J
HJ
Division of Clinical Neurosciences, University of Glasgow, Department of Neurology, Southern General Hospital, Glasgow, UK. h.j.willison@clinmed.gla.ac.uk
D001323:Autoantibodies / Q000378:metabolism*; D005732:Gangliosides / Q000276:immunology*; D020275:Guillain-Barre Syndrome / Q000276:immunology* / Q000378:metabolism*; D006801:Humans
D001323:Autoantibodies; D005732:Gangliosides